HSP90AA1 and juvenile Huntington disease: In addition to the anti-inflammatory effect of Hsp90 inhibitors, the induction of other Hsp chaperones has been recognized as a beneficial effect in experimental disease models of neuronal aggregation diseases, such as Alzheimer’s, Parkinson’s, or Huntington’s diseases [52].